Acute ST-elevation myocardial infarction
Eric R Bates1, Daniel S Menees
1Division of Cardiovascular Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. ebates@umich.edu
Insights
Rapid treatment for ST-elevation myocardial infarction (STEMI) is crucial. Percutaneous coronary intervention (PCI) is the best strategy, supported by advanced therapies and rapid transport to specialized centers.
Area of Science:
- Cardiology
- Emergency Medicine
Background:
- Acute ST-elevation myocardial infarction (STEMI) significantly impacts morbidity, mortality, and disability.
- Timely and effective treatment is essential for improving patient outcomes.
Purpose of the Study:
- To review recent advancements in the management of STEMI patients.
- To highlight optimal treatment strategies and emerging therapies.
Main Methods:
- Review of current literature on STEMI treatment.
- Analysis of prehospital and interhospital transfer protocols.
- Evaluation of pharmacological and device-based adjunctive therapies.
Main Results:
- Rapid transport to a percutaneous coronary intervention (PCI) center is the optimal prehospital strategy.
- Coronary angiography is recommended for all STEMI patients.
- Advances include drug-eluting stents, thrombus aspiration, systemic hypothermia, and stem cell therapy evaluations.
Conclusions:
- Primary PCI with prompt stent implantation is the gold standard for STEMI treatment.
- Optimal antithrombotic agents include aspirin, bivalirudin, and prasugrel or ticagrelor.
- Systemic hypothermia shows promise for cardiac arrest survivors; stem cell therapy benefits require further proof.
Purpose Of Review:
Acute ST-elevation myocardial infarction (STEMI) is a major cause of morbidity, mortality, and disability. This review summarizes recent advances in the treatment of patients with STEMI.
Recent Findings:
The best prehospital and interhospital transfer strategy for patients with STEMI is rapid transport to a percutaneous coronary intervention (PCI) center by Emergency Medical Services, with prehospital diagnosis and activation of the cardiac catheterization laboratory. Coronary angiography is now recommended for all patients with STEMI. Advances in adjunctive pharmacological and device therapy have improved primary PCI results. Thrombus aspiration, drug-eluting stents, systemic hypothermia for survivors of cardiac arrest with anoxic encephalopathy, and stem cells as reparative therapy have undergone recent evaluation.
Summary:
Primary PCI with stent implantation as soon as possible is the best treatment strategy for patients with STEMI. Aspirin, bivalirudin, and either prasugrel or ticagrelor are the best antithrombotic agents to support primary PCI. Thrombus aspiration and intra-aortic balloon counterpulsation are important device adjuncts. Systemic hypothermia appears to be an important advance for survivors of cardiac arrest with anoxic encephalopathy, but the benefits of stem cell therapy have yet to be proven.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome V: Nursing Management

